Therapeutic Asset Ratings

5,098 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Tislelizumab Colorectal Cancer	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	P3	B (61)
Tislelizumab Lung Cancer	Gustave Roussy, Cancer Campus, Grand Paris	P3	B (61)
Tislelizumab Diffuse Large B-Cell Lymphoma	Ningbo No. 1 Hospital	P3	B (61)
Venetoclax Cancer	AbbVie	P3	B (61)
Vorolanib Renal Cell Carcinoma	Peking University Cancer Hospital & Institute	P3	B (61)
xw003 Obesity Disorder	Hangzhou Sciwind Biosciences Co., Ltd.	P3	B (61)
10-(1-methylpiperidin-4-ylidene)-5,10-dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-one Peripheral Neuropathy	Tanta University	P3	B (60)
25-HYDROXYCALCIFEROL Prostate Adenocarcinoma	University of Ilorin Teaching Hospital	P3	B (60)
25-HYDROXYCALCIFEROL Neoplasm	University of Ilorin Teaching Hospital	P3	B (60)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Brain Neoplasm	Children's Cancer Hospital Egypt 57357	P3	B (60)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Inflammatory Disease	University Tunis El Manar	P3	B (60)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Morbid Obesity	Cairo University	P3	B (60)
4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)- Pelvic Congestion Syndrome	Pirogov Russian National Research Medical University	P3	B (60)
6-(3-(4-(O-METHOXYPHENYL)-1-PIPERAZINYL)PROPYLAMINO)-1,3-DIMETHYLURACIL Ischemic Stroke	Second Affiliated Hospital, School of Medicine, Zhejiang University	P3	B (60)
9-valent human papillomavirus recombinant vaccine Anogenital Human Papillomavirus Infection	Xiamen University	P3	B (60)
9-valent human papillomavirus recombinant vaccine Penile Cancer	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)
9-valent human papillomavirus recombinant vaccine Intraepithelial Neoplasia	Xiamen University	P3	B (60)
9-valent human papillomavirus recombinant vaccine Prostate Intraepithelial Neoplasia	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)
9-valent human papillomavirus recombinant vaccine Grade III Prostatic Intraepithelial Neoplasia	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)
Abatacept Recombinant Juvenile Myelomonocytic Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P3	B (60)
Abemaciclib Chemotherapy-Induced Toxicity	Eli Lilly and Company	P3	B (60)
Abemaciclib Basal-Like Breast Carcinoma	Danish Breast Cancer Cooperative Group	P3	B (60)
Abemaciclib Melanoma, Cutaneous Malignant, Susceptibility To, 3	Eli Lilly and Company	P3	B (60)
Abemaciclib Microcephaly 12, Primary, Autosomal Recessive	Eli Lilly and Company	P3	B (60)
Abemaciclib Non-Small Cell Lung Carcinoma	Tango Therapeutics, Inc.	P3	B (60)

Showing 2701 to 2725 of 5,098 assets

PreviousPage 109 of 204Next